http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11504034-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1996-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H11504034-A |
| titleOfInvention | Quinazoline derivatives |
| abstract | (57) [Summary]nThe present invention relates to a quinazoline derivative 6- (2-methoxyethylamino) -7-methoxy-4- (3'-methylanilino) quinazoline or a pharmaceutically acceptable salt thereof, a method for producing the same, a drug containing the compound and The use of the receptor tyrosine kinase inhibitory properties of the compounds for the treatment of proliferative diseases such as cancer. |
| priorityDate | 1995-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 259.